4//SEC Filing
WILBER ROBERT J 4
Accession 0001178913-10-000307
CIK 0000793279other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 12:31 PM ET
Size
28.8 KB
Accession
0001178913-10-000307
Insider Transaction Report
Form 4
WILBER ROBERT J
VP European Operation
Transactions
- Disposition to Issuer
Incentive Stock Option (right to buy)
2010-01-05−5,862→ 0 totalExercise: $11.98Exp: 2014-01-29→ Common Stock, $0.01 par value per share (5,862 underlying) - Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−60,000→ 0 totalExercise: $4.29Exp: 2018-01-25→ Common Stock, $0.01 par value per share (60,000 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2010-01-05−15,000→ 0 totalExercise: $11.96Exp: 2014-01-26→ Common Stock, $0.01 par value per share (15,000 underlying) - Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−30,000→ 0 totalExercise: $11.53Exp: 2017-04-03→ Common Stock, $0.01 par value per share (30,000 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2010-01-05−20,000→ 0 totalExercise: $4.67Exp: 2013-04-29→ Common Stock, $0.01 par value per share (20,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−9,999→ 0 totalExercise: $9.50Exp: 2015-02-11→ Common Stock, $0.01 par value per share (9,999 underlying) - Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−9,138→ 0 totalExercise: $11.98Exp: 2014-01-29→ Common Stock, $0.01 par value per share (9,138 underlying) - Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−30,000→ 0 totalExercise: $15.33Exp: 2016-01-30→ Common Stock, $0.01 par value per share (30,000 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2010-01-05−1→ 0 totalExercise: $9.50Exp: 2015-02-11→ Common Stock, $0.01 par value per share (1 underlying) - Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−24,388→ 0 totalExercise: $0.41Exp: 2019-01-19→ Common Stock, $0.01 par value per share (24,388 underlying)
Footnotes (10)
- [F1]The stock-settled stock appreciation rights, which were exercisable in four equal installments beginning on January 30, 2007, were vested in full and assumed by Syneron Medical Ltd. ("Syneron") pursuant to a merger agreement between the Issuer and Syneron and replaced with stock-settled stock appreciation rights to purchase 8,733 ordinary shares of Syneron at an exercise price of $52.67 per share.
- [F10]The incentive stock options, which were exercisable in four annual installments beginning on April 29, 2004, were vested in full and assumed by Syneron as a result of the merger and replaced with incentive stock options to purchase 5,822 ordinary shares of Syneron at an exercise price of $16.05 per share.
- [F2]The incentive stock options, which were exercisable in one installment beginning on February 11, 2005, were vested in full and assumed by Syneron as a result of the merger and replaced with incentive stock options to purchase 0 ordinary shares of Syneron at an exercise price of $32.64 per share.
- [F3]The non-qualified stock options, which were exercisable in four equal installments beginning on February 11, 2005, were vested in full and assumed by Syneron as a result of the merger and replaced with non-qualified stock options to purchase 2,910 ordinary shares of Syneron at an exercise price of $32.64 per share.
- [F4]The incentive stock options, which were exercisable in four annual installments beginning on January 29, 2005, were vested in full and assumed by Syneron as a result of the merger and replaced with incentive stock options to purchase 1,706 ordinary shares of Syneron at an exercise price of $41.16 per share.
- [F5]The non-qualified stock options, which were exercisable in three annual installments beginning on January 29, 2005, were vested in full and assumed by Syneron as a result of the merger and replaced with non-qualified stock options to purchase 2,660 ordinary shares of Syneron at an exercise price of $41.16 per share.
- [F6]The incentive stock options, which were exercisable in four equal installments beginning on January 26, 2005, were vested in full and assumed by Syneron as a result of the merger and replaced with incentive stock options to purchase 4,366 ordinary shares of Syneron at an exercise price of $41.09 per share.
- [F7]The stock-settled stock appreciation rights, which were exercisable in two equal installments beginning on January 19, 2010, were vested in full and assumed by Syneron as a result of the merger and replaced with stock-settled stock appreciation rights to purchase 7,099 ordinary shares of Syneron at an exercise price of $1.41 per share.
- [F8]The stock-settled stock appreciation rights, which were exercisable in four equal installments beginning on January 25, 2009, were vested in full and assumed by Syneron as a result of the merger and replaced with stock-settled stock appreciation rights to purchase 17,466 ordinary shares of Syneron at an exercise price of $14.74 per share.
- [F9]The stock-settled stock appreciation rights, which were exercisable in four equal installments beginning on April 3, 2008, were vested in full and assumed by Syneron as a result of the merger and replaced with stock-settled stock appreciation rights to purchase 8,733 ordinary shares of Syneron at an exercise price of $39.61 per share.
Documents
Issuer
CANDELA CORP /DE/
CIK 0000793279
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001233048
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 12:31 PM ET
- Size
- 28.8 KB